Semler Scientific Acquisition & Valuation

Semler Scientific was acquired by Strive for $1.4B in September 2025, a 33.0x multiple on $43M of revenue.

Semler Scientific acquisition price

$1.4B

Acquired by Strive · Sep 2025

Semler Scientific revenue at acquisition

$43M

Last twelve months · Sep 2025

Semler Scientific revenue multiple at acquisition

33.0x

EV/Revenue · Sep 2025

Semler Scientific EBITDA multiple at acquisition

64.5x

EV/EBITDA · Sep 2025

Semler Scientific Overview

About Semler Scientific

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.


Founded

2007

HQ

United StatesPortland, OR

Status

Acquired

Customer focus

B2B

Revenue model

Product sales

Revenue

$43M (Sep 2025)

Valuation

$1.4B (acquired Sep 2025)

Semler Scientific Acquisition

Semler Scientific was acquired by Strive for $1.4B on 22 September 2025.

The acquisition price implies a 33.0x revenue and 64.5x EBITDA multiple on $43M of revenue.

Semler Scientific develops and markets patented products for early detection of chronic diseases, including the QuantaFlo non-invasive vascular testing device used for peripheral arterial disease screening, and adopted a Bitcoin treasury strategy holding over 5,000 BTC. Strive, Inc. (Nasdaq: ASST), parent of Strive Asset Management, LLC, manages over $2 billion in assets across 13 ETFs and positions itself as the first publicly traded asset management Bitcoin treasury company, focused on increasing Bitcoin per share through capital raises like a $762.6 million PIPE and $450 million ATM program. On September 22, 2025, Strive announced an all-stock merger to acquire 100% of Semler Scientific for approximately $1.34-$1.42 billion equity value, exchanging each SMLR share for 21.05 Strive Class A shares at a 210% premium implying $90.52 per share; concurrent with signing, Strive purchased 5,816 BTC for $675 million, boosting combined holdings to over 10,900 BTC. Shareholders approved the deal, with Semler contributing 5,048.1 BTC, and Strive completed the acquisition on January 16, 2026, becoming the 11th largest corporate Bitcoin holder with ~12,797.9 BTC. Strategic rationale centers on combining two leading public Bitcoin treasuries to enhance Bitcoin per share and equity value accretion without debt, while Strive plans to monetize Semler's diagnostics business within 12 months by expanding into preventative healthcare under new leadership modeled after Roivant Sciences, potentially distributing it at 5x revenue multiple for ~$215 million gain and retiring Semler's $100 million convertible note and $20 million Coinbase loan. Post-close appointments include Avik Roy as Chief Strategy Officer for business expansion, Eric Semler as independent board director, and Joe Burnett as VP of Bitcoin Strategy.

Semler Scientific acquisition details
AcquirerDateTypePriceEV/RevenueEV/EBITDA
22 Sep 2025PE buyout$1.4B33.0x64.5x

Semler Scientific Competitors

Semler Scientific competitors include listed companies like SonoScape, El.En. Group, Nakanishi and Beijing Balance Medical, and private ones like MindMaze and Science.

Public and private companies comparable to Semler Scientific
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
SonoScapeChinaChinaPublicly listed$347M$35M$1.4B3.4x
El.En. GroupItalyItalyPublicly listed$663M$93M$1.4B2.1x
NakanishiJapanJapanPublicly listed$513M$53M$1.4B2.1x
Beijing Balance MedicalChinaChinaPublicly listed$93M$37M$1.5B-
MindMazeSwitzerlandLausannePrivate--$1.5B-
ScienceUnited StatesSan Francisco, CAPrivate--$1.5B-

Semler Scientific Public Comps

Semler Scientific is no longer listed, but its public comps include SonoScape, El.En. Group, Nakanishi, Nolato, Beijing Balance Medical, Sansure Biotech, Savaria, Conmed, Edge Medical and NovoCure.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
SonoScape$347M$35M3.8x3.4x37.6x29.6x
El.En. Group$663M$93M1.9x2.1x13.4x11.1x
Nakanishi$513M$53M2.4x2.1x23.9x8.1x
Nolato$964M$161M1.4x1.3x8.3x8.4x
Beijing Balance Medical$93M$37M15.8x-39.7x-
Sansure Biotech$246M$49M4.3x4.1x21.8x14.4x
Savaria$652M$112M2.5x2.4x14.7x11.4x
Conmed$1.4B$176M1.7x1.7x13.0x8.2x

This data is available for Pro users. Sign up to see all Semler Scientific competitors and their valuation data.

Start Free Trial

Common questions about Semler Scientific

When was Semler Scientific founded?Semler Scientific was founded in 2007.
Where is Semler Scientific headquartered?Semler Scientific is headquartered in Portland, OR, United States.
Is Semler Scientific publicly listed?No, Semler Scientific was acquired by Strive in September 2025.
Who acquired Semler Scientific?Semler Scientific was acquired by Strive in September 2025.
How much was Semler Scientific acquired for?Semler Scientific was acquired for $1.4B in September 2025, a 33.0x revenue multiple.
Which companies are comparable to Semler Scientific?Companies comparable to Semler Scientific include SonoScape, El.En. Group, Nakanishi, Beijing Balance Medical, MindMaze and Science.

See companies similar to Semler Scientific

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial